BioPoly: Funding, Investors & Team (Oct 2026)
Between the extremes of biological treatments and total joint replacement, BioPoly® was developed to offer a therapeutic option for painful cartilage lesions. The BioPoly® RS devices are specifically created to replace only the damaged cartilage by utilising a proprietary substance that is self-lubricating for increased wear qualities (through a biological augmentation with Hyaluronic Acid). Patients can so swiftly heal and resume pain-free, busy lifestyles. The femoral condyle, trochlear facets, trochlear groove, patella, and humeral head applications for BioPoly® RS devices are already available. Patients who have been followed for more than ten years have reported much less pain and better quality of life. Additional orthopaedic applications are being created right now.
BioPoly has raised $300k across 1 funding round on record, the most recent a Seed of $300k announced in Jan 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioPoly Company Profile and Key Stats
Latest funding round on record: Jan 2023.
BioPoly Funding Rounds
BioPoly Founders and Leadership Team
Contact details for the BioPoly team: 1 of 1 has an email address on file.
Start 14-day free trial →BioPoly Funding Compared to Other Biotechnology Startups
BioPoly's latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioPoly in Biotechnology and Fort Wayne
Companies Similar to BioPoly
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BioPoly Funding FAQs
What does BioPoly do?
Between the extremes of biological treatments and total joint replacement, BioPoly® was developed to offer a therapeutic option for painful cartilage lesions. The BioPoly® RS devices are specifically created to replace only the damaged cartilage by utilising a proprietary substance that is self-lubricating for increased wear qualities (through a biological augmentation with Hyaluronic Acid). Patients can so swiftly heal and resume pain-free, busy lifestyles. The femoral condyle, trochlear facets, trochlear groove, patella, and humeral head applications for BioPoly® RS devices are already available. Patients who have been followed for more than ten years have reported much less pain and better quality of life. Additional orthopaedic applications are being created right now.
How much funding has BioPoly raised?
BioPoly has raised $300k across 1 round on record. The most recent is a Seed of $300k announced in Jan 2023.
When did BioPoly last raise funding?
BioPoly's most recent funding round on record is a Seed of $300k, announced in Jan 2023.
Who is the CEO of BioPoly?
Herb Schwartz is listed as CEO at BioPoly.
Where is BioPoly headquartered?
BioPoly is based in Fort Wayne, Indiana, United States.
How many employees does BioPoly have?
BioPoly is in the 1-10 employee band.
How does BioPoly's funding compare to other Biotechnology startups?
BioPoly's latest round of $300k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioPoly Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioPoly is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.